The Jefferies Global Healthcare Conference, London
16-19 November, 2026
London, UK
Âé¶¹ÆÆ½â°æ is attending The Jefferies Global Healthcare Conference on November 16-19, 2026, in London, engaging with venture investors to discuss near‑ and mid‑term value‑creation across our kidney disease pipeline. It is a great opportunity to share our progress with Vonafexor and its fast follower EYP651, both FXR agonists with anti-inflammatory and fibrolytic properties, developed for kidney diseases.